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Abstract
Background: Characteristics of the physician influence the essential decision-making in end-of-life care. However,
the effect of special education in palliative medicine on different aspects of decision-making in end-of-life care
remains unknown. The aim of this study was to explore the decision-making in end-of-life care among physicians
with or without special competency in palliative medicine (cPM).
Methods: A questionnaire including an advanced lung cancer patient-scenario with multiple decision options in
end-of-life care situation was sent to 1327 Finnish physicians. Decisions to withdraw or withhold ten life-prolonging
interventions were asked on a scale from 1 (definitely would not) to 5 (definitely would) – first, without additional
information and then after the family’s request for aggressive treatment and the availability of an advance directive.
Values from chronological original scenario, family’s appeal and advance directive were clustered by trajectory
analysis.
Results: We received 699 (53%) responses. The mean values of the ten answers in the original scenario were 4.1 in
physicians with cPM, 3.4 in general practitioners, 3.4 in surgeons, 3.5 in internists and 3.8 in oncologists (p < 0.05 for
physicians with cPM vs. oncologists and p < 0.001 for physicians with cPM vs. others). Younger age and not being
an oncologist or not having cPM increased aggressive treatment decisions in multivariable logistic regression
analysis. The less aggressive approach of physicians with cPM differed between therapies, being most striking
concerning intravenous hydration, nasogastric tube and blood transfusions. The aggressive approach increased by
the family’s request (p < 0.001) and decreased by an advance directive (p < 0.001) in all physicians, regardless of
special education in palliative medicine.
Conclusion: Physicians with special education in palliative medicine make less aggressive decisions in end-of-life
care. The impact of specialty on decision-making varies among treatment options. Education in end-of-life care
decision-making should be mandatory for young physicians and those in specialty training.
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Background
Rapid developments in medicine have allowed many in-
terventions for patients with very advanced diseases. At
the same time, the difficulty of choosing worthwhile
therapies for each patient has led to the use of
non-beneficial treatments among dying patients at their
end-of-life (EOL) [1]. In contrast, well-timed palliative
care improves patients’ quality of life and symptom con-
trol and reduces invasive procedures and costs [2–8].
Appropriate decision-making is mandatory in
high-quality EOL-care to prevent non-beneficial treat-
ments and relieve suffering. The decisions include, but
are not limited to, statements on cardiopulmonary re-
suscitation, parenteral fluids, and diagnostic tests. This
decision-making is a challenging process involving many
ethical, legal, medical and psychological aspects [9–16].
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Physicians’ decisions vary concerning different interven-
tions. In a Scandinavian study, 57% of intensive care phy-
sicians would continue intravenous hydration, but only 5%
of them measured blood glucose during EOL-care [17].
Physicians also decide to withdraw therapies less fre-
quently than to withhold them, probably because they feel
withdrawal is more difficult and ethically problematic
[18–21].
In addition to medical facts and personal characteris-
tics, education and specialty of the physician influence
the complex decision-making in EOL [11]. Although
education in palliative care increases the knowledge and
skills needed to perform high-quality EOL-care [22–27],
the effectiveness of special training in palliative medicine
(PM) on different aspects of decision-making in
EOL-care remains unknown.
Most patients wish their closest ones to be involved in
EOL decision-making, and discussions with the family
are essential [28–30]. The families’ opinions are also
shown to influence physicians’ decisions [12, 31, 32], al-
though discordance between patients’ wishes, caregivers’
preferences and caregivers’ predictions of patients’ pref-
erences may exist [28, 33]. Advance directives reinforce
patients’ participation and help with decision-making
[31, 32, 34]. However, there are variations in how ad-
vance directives are understood and taken into account
[12, 35–37].
The aim of our study was to examine whether special
education in PM affects decision-making in EOL-care,
as evaluated by a hypothetical patient scenario with dif-
ferent alternatives. The impact of family requests, writ-
ten advance directives, and physicians’ background
factors on their decisions were analysed.
Methods
Participants
A postal survey with a questionnaire was provided to
1327 Finnish physicians in autumn 2015. The sample
consisted of 500 general health care practitioners (GPs),
300 surgeons, and 300 internists randomly selected from
the register of the Finnish Medical Association. The
sample size is similar to our previous studies done six-
teen years ago and is based on the distribution of differ-
ent specialities in Finland, which has remained largely
unchanged over the years studied [10–12, 38, 39]. In
addition, the questionnaire was send to all Finnish on-
cologists (n = 158) and all physicians with a special com-
petency in PM (n = 82), excluding those with a mailing
proscription (n = 23). Two reminders were send to
nonrespondents.
A cover letter including an introduction to the study
and an assurance of anonymity and voluntariness was
mailed together with the questionnaire. This study was
approved by the Regional Ethics Committee of Tampere
University Hospital, Finland (R15101).
Special competency in palliative medicine
In Finland, postgraduate training in PM leads to a certi-
fication for special competency in PM (cPM) awarded by
the Finnish Medical Association [40]. Finnish physicians
are allowed to start this postgraduate training after
working at least 2 years as a physician. This special
training consists of 150 h of theoretical education in dif-
ferent aspects of PM, 200 patient interactions in pallia-
tive care, 2 years of clinical practice including a working
period in a specialized palliative care unit for a mini-
mum of 3 months, and a final written examination.
Questionnaire
The questionnaire has been previously used and vali-
dated with Finnish physicians. A pilot study was done in
January 1999. The questionnaire was sent to 45 physi-
cians (health care practitioners and specialists) twice at
two-week intervals in order to test the reliability of the
responses to patient scenarios and the questions on atti-
tudes and values. Thirty physicians returned two accept-
able questionnaires. The value of kappa coefficient for
an acceptable scenarios or questions was determined to
be more than 0.40, which is a commonly accepted limit
for reliability. [10–12, 38]
The questionnaire includes seven hypothetical patient
scenarios together with questions concerning re-
sponders’ background, personal features, and attitudes.
In this study, we included one of the patient scenarios
designed to study doctors’ treatment decisions in the
EOL-care. In addition, questions about the responders’
own advance directives, experience in EOL-care among
relatives, treatment of EOL patients within 2 years, avail-
ability of professional supervision, chief position and fi-
nancial responsibility at work together with age and sex
were used as background factors. The parts of the ques-
tionnaire used in this study are available as an
Additional file 1.
Case scenario
The scenario presented a 62-year-old male patient with
pulmonary cancer and metastases. He was admitted to
hospital ward and received high-dose morphine medica-
tion. Due to respiratory weakening, he had become co-
matose the night before.
He also suffered from severe anaemia and had abun-
dant pleural effusion and fever.
After the presentation of the patient scenario, there
was a question about the treatment decision: Which of
the following treatments already started (*) or planned
would you withhold or withdraw? In the first situation,
there was no possibility of discussing the matter with
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the family and there was no advance directive. The deci-
sion responses were expressed on a scale from 1 (I defin-
itely would not) to 5 (I definitely would). The treatments
were a) antibiotics (*); b) mechanical ventilation (*); c)
blood transfusion; d) pleural drainage; e) chest x-ray
examination; f ) laboratory tests; g) intravenous hydration
(*); h) nasogastric tube (*); i) thrombosis prophylaxis (*);
and j) supplementary oxygen (*).
After the original patient scenario, two alternatives
with extra information were provided: 1) the patient’s
daughters come to you distressed and crying, express-
ing their hope that everything possible will be done
to save their father’s life; 2) there is a written advance
directive in the patient’s medical chart in which he
expresses his wish that all active treatment should be
withdrawn if there is no hope for recovery. After each
of these alternatives the same questions (with the
same treatment options as in the original scenario)
were asked. Questions were asked to be answered in
the given order and not to change answers once
decided.
Statistical analysis
Different responder groups were compared by t-test for
normally distributed continuous variables (Fig. 1) and by
chi-square or Fisher’s exact tests when appropriate for
categorical variables (Tables 2 and 3). The answers on
the 5-step Likert scale in the scenarios were converted
to a 2-step scale: 1–3, “would not withdraw or withhold
and don’t know” and 4–5, “would withdraw or with-
hold”. Measured mean distributions of the chronological
original scenario, family’s appeal and advance directive
values were clustered by trajectory analysis [41]. The tra-
jectories were created according to the measurements of
mean values in each responder as a continuous outcome
measure. The analyses undertaken were latent class mix-
ture models of quadratic trajectories including a random
intercept and concomitant variables. Models were fitted
Fig. 1 Mean values of all ten answers concerning willingness to withhold or withdraw therapies (scale from 1 = definitely would not to 5 = definitely
would) in the patient case according to different scenarios and physician groups
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by using the flexmix package [42] of the statistical pro-
gram R, version 3.3.0, from the R Foundation for Statis-
tical Computing (R Development Core Team. R: A
language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria,
2008, ISBN 3–900,051–07-0, URL). Relative goodness of
fit was assessed using Bayesian information Criteria.
Factors (Table 4) affecting the willingness to continue
or start therapies (belonging to trajectory groups 3 or 4)
compared to withhold or withdraw therapies (belonging
to trajectory groups 1 or 2) were examined by univariate
and age-adjusted logistic regression models results
shown by odds ratios (OR) with 95% confidence inter-
vals (CI). Additionally, a multivariable model, where var-
iables were added simultaneously into the model, was
performed for variables with statistical significance
under 0.20 in age-adjusted model. Two-sided p-values of
less than 0.05 were accepted as statistically significant.
Data-analyses were performed using IBM SPSS Statistics




Altogether, 699 valid responses were achieved (re-
sponse rate 53%). The response rate ranged from 82%
among physicians with cPM to 47% among surgeons.
Characteristics of the responders are presented in
Table 1. A majority of the responders were women,
except in the group of surgeons. The median age of
the responders was 52 years (interquartile range 43–
58), with slight variations between the groups. Most
of the GPs worked at out-patient clinics (85%), while
the others mainly worked at hospitals (66–87%).
Overall willingness to withhold or withdraw therapies
The mean values of all ten answers according to the
three alternatives in the case scenario are shown in
Fig. 1. Physicians with cPM were most willing to
withhold and withdraw interventions, especially com-
pared to GPs, internists and surgeons. The family’s
appeal significantly increased the willingness to start
or continue life-prolonging therapies in all physician
groups, whereas the advance directive decreased it
(p < 0.001 compared to the original scenario).
Decisions concerning individual treatments
Physicians with cPM were more willing to withdraw
and withhold most of the individual interventions,
compared to the others (Tables 2 and 3). This differ-
ence in decision-making was most striking in with-
drawing intravenous hydration, removing nasogastric
tube and withholding blood transfusions. In contrast,
some decisions (e.g., withdrawing oxygen or antibi-
otics) varied only slightly between the physicians
with cPM and others. Mechanical ventilation was
withdrawn by most of the physicians, while supple-
mentary oxygen was frequently continued by all
responders.
The daughters’ request for “everything to be done”
(the family’s appeal) increased the willingness to con-
tinue or start each life-prolonging treatment, with the
only exception the use of oxygen among cPMs. The
daughters’ request had the largest influence on the
decisions concerning intravenous hydration and diag-
nostic tests (Table 2).
The availability of the advance directive markedly
moved decisions towards withdrawing and withhold-
ing treatments. Although the differences between re-
sponder groups diminished, the physicians with cPM
and the oncologists still had the least aggressive ap-
proach. Nearly all physicians withdrew mechanical
ventilation, discontinued thrombosis prophylaxis and
withheld blood transfusion. However, over one third
of the physicians without cPM continued intravenous
hydration, and supplementary oxygen was frequently
continued by all physicians.
Table 1 Characteristics of the participants
Competency in PM Surgeons Internists GPs Oncologists Total
Number (% of total) 67 (10) 142 (20) 153 (22) 245 (35) 92 (13) 699 (100)
Response rate, % 82 47 51 49 63 53
Female, n (%) 57 (85) 47 (33) 81 (53) 173 (71) 73 (79) 431 (62)
Median age (IQR) 55 (49–58) 52 (44–59) 53 (46–59) 49 (38–57) 49 (41–56) 52 (43–58)
Age distribution, n (%)
< 35 0 (0) 4 (3) 4 (3) 42 (17) 2 (2) 52 (7)
35–49 20 (30) 52 (37) 51 (33) 84 (34) 46 (50) 253 (36)
> 49 47 (70) 86 (61) 98 (64) 119 (49) 44 (48) 394 (56)
Years from graduation, median (IQR)a 27 (21–32) 26 (17–34) 26 (20–32) 21 (9–31) 22 (14–29) 25 (15–32)
PM, Palliative Medicine, GP, General Practitioner, IQR, Interquartile Range
aFor nine participants year of graduation was not available
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Trajectory analysis and factors associated with aggressive
treatment decisions
When answers were fitted with a trajectory analysis, four
differently behaving groups were found (Fig. 2). In the tra-
jectory group 1, responders were consistently willing to
withdraw and withhold therapies, and in the trajectory
group 2, physicians would probably withdraw and withhold
therapies, but their decisions were influenced by the family’s
appeal and the advance directive. In contrast, responders
encompassed in the trajectory group 3 were either uncer-
tain or chose an aggressive approach in about half of their
decisions, and they were more influenced by the advance
directive, while physicians in the trajectory group 4 were
most hesitant to withdraw and withhold therapies.
Table 2 Number and proportion (%) of physicians deciding to withdraw a treatment in the patient scenario according to physician
groups
Treatment Scenario Competency in PM Surgeons Internist GPs Oncologists P-valuea
Antibiotic Original scenario 41 (65) 72 (51) 78 (51) 128 (53) 45 (54) 0.399
Family’s appeal 33 (50) 55 (39) 55 (36) 89 (37)* 34 (37) 0.353
Advance directive 58 (87) 116 (83) 122 (82) 204 (84) 82 (89) 0.641
Mechanical ventilation Original scenario 63 (96) 119 (85)* 135 (89) 195 (81)* 83 (91) 0.008
Family’s appeal 59 (92) 113 (80)* 126 (83) 175 (72)* 76 (84) 0.002
Advance directive 67 (100) 130 (92)* 147 (98) 228 (94)* 90 (99) 0.011
Intravenous hydration Original scenario 43 (65) 31 (22)** 39 (26)** 85 (35)** 42 (46)* < 0.001
Family’s appeal 26 (40) 21 (15)** 19 (13)** 58 (24)* 34 (37) < 0.001
Advance directive 58 (88) 64 (46)** 84 (56)** 162 (67)* 75 (82) < 0.001
Nasogastric tube Original scenario 62 (95) 85 (60)** 98 (65)** 161 (67)** 63 (69)** < 0.001
Family’s appeal 60 (92) 76 (54)** 87 (58)** 126 (53)** 64 (70)* < 0.001
Advance directive 64 (97) 105 (75)** 126 (84)* 203 (84)* 82 (89) 0.001
Thrombos prophylaxis Original scenario 55 (85) 108 (76) 105 (69)* 151 (62)* 73 (80) < 0.001
Family’s appeal 52 (80) 104 (74) 95 (64)* 128 (53)** 67 (73) < 0.001
Advance directive 63 (96) 121 (88) 127 (85)* 199 (82)* 86 (94) 0.013
Supplementary oxygen Original scenario 11 (16) 16 (11) 23 (15) 14 (6)* 11 (12) 0.019
Family’s appeal 12 (18) 14 (10) 13 (9)* 12 (5) 6 (7)* 0.011
Advance directive 20 (30) 40 (28) 46 (31) 51 (21) 27 (29) 0.189
PM, Palliative Medicine, GP, General Practitioner
aGlobal p-value across all physician groups
*p < 0.05 and **p < 0.001 pair-wise comparison to physicians with special competency in PM
Table 3 Number and proportion (%) of physicians deciding to withhold an intervention in the patient scenario according to
physician groups
Treatment Scenario Competency in PM Surgeons Internists GPs Oncologists P-valuea
Blood transfusion Original scenario 60 (91) 98 (70)* 108 (72)* 185 (76)* 72 (78)* 0.011
Family’s appeal 55 (85) 90 (64)* 85 (56)** 153 (64)* 67 (76) < 0.001
Advance directive 66 (99) 132 (94) 136 (91) 227 (94) 90 (98) 0.134
Pleural drainage Original scenario 43 (65) 59 (42)* 85 (56) 99 (41)** 58 (64) < 0.001
Family’s appeal 41 (63) 57 (40)* 73 (49) 89 (37)** 51 (56) < 0.001
Advance directive 53 (79) 103 (73) 119 (80) 179 (74) 82 (89) 0.030
Chest X-ray Original scenario 51 (77) 66 (47)** 88 (58)* 119 (60)** 67 (73) < 0.001
Family’s appeal 44 (67) 61 (43)* 74 (49)* 29 (38)** 59 (65) < 0.001
Advance directive 59 (88) 111 (79) 124 (83) 194 (81) 90 (98)* 0.001
Laboratory tests Original scenario 49 (74) 70 (59)* 87 (57)* 121 (50)* 59 (64) 0.002
Family’s appeal 40 (61) 60 (43)* 67 (45)* 85 (35)** 51 (56) < 0.001
Advance directive 58 (87) 115 (81) 119 (78) 190 (78) 88 (96)* 0.006
PM, Palliative Medicine, GP, General Practitioner
aGlobal p-value across all physician groups
*p < 0.05 and **p < 0.001 pair-wise comparison to physicians with special competency in PM
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Factors associated with the physicians’ willingness to
continue or start life-prolonging therapies during
EOL-care (belonging to trajectory groups 3 or 4) com-
pared to withhold or withdraw therapies (belonging to
trajectory groups 1 or 2) are shown in Table 4. By multi-
variable analysis, younger age and being an internist,
surgeon or GP were independent factors behind the de-
cisions not to withhold - or to withdraw – different in-
terventions. In contrast, gender, being in chief-position,
having financial responsibility, or a physician’s own ad-
vance directive and experience in EOL-care among rela-
tives did not have independent influence.
Discussion
We found that physicians with cPM were more willing to
withdraw and withhold life-prolonging therapies, espe-
cially intravenous hydration and a nasogastric tube, in a
patient scenario representing EOL-care. The family’s re-
quest increased the aggressive approach in all physicians,
whereas the availability of an advance directive decreased
this. Younger age and being an internist, surgeon or GP
without cPM were independent factors for responses
reflecting willingness to start or continue life-prolonging
treatments in multivariable regression analysis.
In this study, the overall willingness to withhold and
withdraw therapies in EOL-care was higher in physicians
with cPM, measured by mean values of all the answers
and in a multivariable regression analysis, although oncol-
ogists and cPMs differed only slightly. We used trajectory
analysis to take into account all the scenarios in the given
order and found a similar pattern across all four groups.
Therefore, the groups starting from a low willingness to
withhold or withdraw therapies in the original scenario
were finally chosen to be presented in the multivariable
analysis. In light of previous studies [43–45], it is under-
standable that physicians with formal training in PM have
good ability to consider and communicate the EOL deci-
sions, probably leading to more decisions to withdraw and
Fig. 2 Distribution of the responses (scale from 1 = definitely would not to 5 = definitely would) in the original scenario, family’s appeal and
advance directive in the trajectory analysis
Piili et al. BMC Palliative Care  (2018) 17:94 Page 6 of 11
withhold treatments. We suggest that this willingness is
related to the cPM itself as its influence remained also
after multivariate analysis taking into account some im-
portant background factors in our study. We have to state,
however, that we don’t know all the attitudes, which might
drive physicians to special education in PM and whether
these factors also predispose to withholding and with-
drawing life-sustaining treatments.
As our case represented a cancer patient, it is not sur-
prising that responses among physicians with cPM and
oncologists were quite similar, although there were dif-
ferences concerning individual interventions. The rela-
tive unwillingness of GPs to make decisions for a
palliative approach is a bit concerning, since a vast ma-
jority of dying patients in Finland are cared for by GPs.
This result was independent of the GPs’ younger age.
Our results highlight the need for education in PM start-
ing from medical school and continuing throughout spe-
cialty training. In addition, palliative care consultations
have shown to be beneficial and they should be offered
to all specialities to help complex decision-making in
EOL-care [6, 46–48].
Younger age was associated with unwillingness to
withhold and withdraw therapies in our study. Age
seems to be a contradictory factor in decision-making
[49]. In some studies, including our own, older age has
been associated with more decisions to withhold or
withdraw interventions [50, 51], while in others, younger
physicians or trainees make less aggressive decisions
[52–54]. Younger physicians have less experience in
Table 4 Factors associated with the willingness to continue or start life prolonging therapies (belonging to trajectories 3 or
4) compared to withhold or withdraw therapies (belonging to trajectories 1 or 2) in the patient scenario presented by
univariate, age-adjusted and multivariable analysis
Univariate Age-adjusted Multivariate
n OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age continuous, years 692 0.96 (0.95–0.98) < 0.001
Age < 0.001 0.002
25–35 52 4.71 (2.35–9.44) 3.19 (1.54–6.57)
35–49 253 1.49 (1.08–2.05) 1.46 (1.03–2.06)
50–67 387 1.00 1.00
Sex 0.796 0.433
Female 425 1.04 (0.77–1.41) 0.88 (0.64–1.21)
Male 267 1.00 1.00
Chief-position 0.013 0.208
No 480 1.51 (1.09–2.11) 1.25 (0.88–1.76)
Yes 205 1.00 1.00
Financial responsibility 0.006 0.083 0.183
No 562 1.75 (1.17–2.62) 1.44 (0.95–2.19) 1.35 (0.87–2.08)
Yes 120 1.00 1.00 1.00
Own advance directive 0.604 0.932
No 638 1.17 (0.65–2.09) 1.03 (0.57–1.86)
Yes 49 1.00 1.00
End-of-life care among relatives 0.066 0.322
No 336 1.32 (0.98–1.79) 1.17 (0.86–1.59)
Yes 352 1.00 1.00
Physician group < 0.001 < 0.001 < 0.001
Competency in PM 66 1.00 1.00 1.00
Oncologists 92 1.63 (0.78–3.40) 1.39 (0.66–2.93) 1.61 (0.75–3.46)
Internists 150 3.92 (2.00–7.67) 3.85 (1.96–7.57) 4.27 (2.13–8.56)
Surgeons 142 4.53 (2.30–8.90) 4.37 (2.21–8.64) 4.51 (2.25–9.07)
GPs 242 6.27 (3.29–12.0) 5.34 (2.78–10.3) 5.60 (2.85–11.0)
Significant results (p < 0.05) bolded and nearly significant (p < 0.10) shown by italic font
Age-adjusted significant (p < 0.05) or nearly significant (p < 0.10) variables included into the multivariate model. Missing values were not analyzed
PM, Palliative Medicine, GP, General Practitioner
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EOL-care, but on the other hand, PM is currently in-
cluded in the curriculum of many medical schools, in-
creasing younger colleagues’ awareness of the benefits of
palliative care. After 1999 two out of the five medical
schools in Finland has included an undergraduate cur-
riculum in PM fulfilling the European recommendations
[55, 56]. Our results are in line with other studies show-
ing that gender does not influence the decision-making
[51, 54]. Some of the other background factors (such as
experience in EOL-care with loved ones or a physician’s
own advance directive) did not influence the
decision-making in our study, but are not included in
previous studies.
Our results imply, that decisions to withhold or with-
draw therapies in a clinical practise is mainly driven by
medical education and clinical experience of a physician
and preferences of a patient rather than doctor’s personal
life experience or attitudes.
Advance directive and a healthcare proxy or the family’s
opinion have been shown to have marked influence on
physicians’ decision-making [12, 31, 35, 57, 58], but there
are no earlier studies about this for palliative care physi-
cians. Our study is in line with previous ones [31, 32],
since the family’s request for aggressive treatments signifi-
cantly increased physicians’ willingness to continue or
start life-prolonging therapies, and advance directive de-
creased this. This finding was constant through different
physician groups including physicians with cPM. Commu-
nication and shared decision-making are very important
in EOL-care [20, 49–54, 57, 58], but futile therapies
should not be used (even if families have requested them),
as stated by the Finnish National Supervisory Authority
for Welfare and Health [59]. Therefore, this clear influ-
ence of family requests on decision-making is controver-
sial and perhaps an issue needing more attention in the
education of PM, which should also introduce legal as-
pects and official recommendations on decision-making.
Knowing a patient’s own will helps in decision-making
[31, 32], and an advance directive naturally moves the de-
cisions towards a palliative approach. However, the con-
tent of an advance directive presented here did not
describe the patient’s will in detail, which is often the case
in the real world as well. The understanding of “active
treatments” probably influenced the decisions concerning
individual therapies in the present study and calls for
more detailed advanced care planning and advance direc-
tives in clinical practice.
The differences in decision-making between physicians
with cPM and others were most striking for nasogastric
tube and intravenous hydration. Surgeons, internists and
to a lesser extent GPs were unwilling to withdraw hydra-
tion, even when an advance directive was found. Artificial
nutrition or medically assisted hydration has not been
shown to improve survival, quality of life or symptoms in
EOL-care, although the evidence about this is scarce [60–
64]. There are studies, however, raising concerns about
the potential harms, such as increased respiratory secre-
tions, related to hydration during EOL [65]. Although the
use of artificial nutrition or intravenous hydration in
EOL-care remains controversial, the case scenario in our
study represented a dying patient in which these therapies
can be considered non-beneficial. The pros and cons of
these therapies are included in the formal training in PM,
but are probably quite unfamiliar to other physicians.
Supplementary oxygen was the least withdrawn treat-
ment in our study, even among physicians with cPM. This
result is in line with reports showing that oxygen is used
in more than 70% of patients in EOL-care [66, 67], al-
though the evidence to support this is lacking [68–70].
Perhaps this unwillingness to withdraw oxygen is related
to the presumption of its benefit and harmlessness, al-
though it may cause dryness of the mouth and aggravate
communication.
In our study antibiotics were withdrawn by about half of
the physicians. Use of antibiotics in EOL is controversial,
but there is some evidence that antibiotics might relieve
symptoms without serious side-effects, which might ex-
plain the unwillingness to withdraw them [71, 72]. Inter-
nists and GPs were more unwilling to withdraw
thrombosis prophylaxis compared to others, probably due
to their familiarity with the indications of anticoagulation
in the general population. There are no controlled studies
to guide when to stop anticoagulation in palliative care,
but as our case represented a dying person, withdrawing it
can be considered reasonable [73].
The benefits of transfusions in palliative care are expe-
rienced briefly and remain controversial [74]. In our
study, the physicians with cPM withheld blood transfu-
sions more frequently than others, although the avail-
ability of an advance directive increased the willingness
to over 90% in all groups.
Pleural drainage can alleviate dyspnoea, but this is an in-
vasive procedure including some risks in EOL-care [75].
Surgeons and GPs were most eager to perform this pro-
cedure, which probably reflects their willingness to per-
form chest X-rays as well. In a Scandinavian study,
intensive care physicians withheld laboratory tests [17]
more often than all the physicians in our study, which is
somewhat surprising. Changing from cure to care might
be more complex in a common hospital ward compared
to an intensive care unit (ICU), where withdrawing
life-supporting treatments commonly leads to relatively
rapid patient death.
Limitations
Some limitations of this study need to be acknowledged.
Our response rate (53%) is higher than in many of the
recent surveys [31, 37, 76], but still sets a limitation.
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Although there might be some nonresponse bias, our
responders can be considered a representative sample of
Finnish physicians providing insight into their
decision-making. The distribution of physician groups in
the study equals the distribution of different specialities in
Finland [39]. Similarly, the high proportion of female re-
spondents in our study is understandable, since 60% of
physicians in Finland are women and female dominance is
true among all the specialities studied excluding surgeons
[39]. Answers to hypothetical scenarios might differ from
physicians’ decision -making in real life situations. In
addition, the scenario forced the responder to give simple
“yes” or “no” answer without the possibility for example to
discuss with the family to achieve shared decision. Further
studies on physicians’ decision-making in clinical practice
are needed, although this might be difficult to study in
large physician groups, as each clinical circumstance is
very different. We suggest, however, that the factors be-
hind decision-making remain similar in real life situations
and in our hypothetical scenarios. Finally, most of the
treatments in our case clearly intend to prolong life (e.g.,
mechanical ventilation), while some of them may be partly
considered as supporting ones (e.g., pleural drainage).
Similarly, oxygen or transfusions may be given for symp-
tom relief only or to prolong life, which should be
distinguished.
Therefore, “palliative” or “life-prolonging” intent may be
questioned in some decisions, but we suggest that the
overall tendency to withdraw or withhold therapies in our
study reflects reasonable decision-making in EOL-care.
The intention itself behind these decisions is an interest-
ing subject for future studies.
Conclusions
Physicians with special education in palliative medicine
are more willing to withdraw and withhold life-prolonging
therapies in EOL-care. This is especially true concerning
decisions on hydration, artificial nutrition and transfu-
sions. Families’ request and advance directives have a sig-
nificant influence on decision-making in all physicians.
Younger age and specialty of a physician are main
factors influencing the willingness to start or continue
life-prolonging treatments. Therefore, education about
decision-making in EOL-care should be mandatory at
medical schools and in the training of all the special-
ities facing dying patients. Palliative care consultations
might be needed for complex cases of decision -mak-
ing in EOL-care.
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